E-LIB Suche - Ergebnisse für: Shaman, Heena

1

Immunogenicity and safety of Biological E's CORBEVAX™ vacci..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, SubbaReddy...
Human Vaccines & Immunotherapeutics. 19 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

2

Resolution of viral load in mild COVID-19 patients is assoc..:

Anantharaj, Anbalagan ; Gujjar, Sunil ; Verma, Nikhil...
Journal of Clinical Virology. 146 (2022) - p. 105060 , 2022

Link: https://doi.org/10.1016/..

3

Safety, tolerability and immunogenicity of Biological E's C..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, SubbaReddy...
Vaccine. 40 (2022) 49 - p. 7130-7140 , 2022

Link: https://doi.org/10.1016/..

4

Sub-optimal neutralisation of omicron (B.1.1.529) variant b..:

Medigeshi, Guruprasad R ; Batra, Gaurav ; Murugesan, Deepika Rathna...
eBioMedicine. 78 (2022) - p. 103938 , 2022

Link: https://doi.org/10.1016/..

5

Humoral cross-reactivity towards SARS-CoV-2 in young childr..:

Dhochak, Nitin ; Agrawal, Tanvi ; Shaman, Heena...
Journal of Clinical Virology Plus. 2 (2022) 1 - p. 100061 , 2022

Link: https://doi.org/10.1016/..

6

Pre-existing antibody levels negatively correlate with anti..:

Das, Suman ; Singh, Janmejay ; Shaman, Heena...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

7

Evaluation of safety and immunogenicity of receptor-binding..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, Subba Reddy...
eBioMedicine. 83 (2022) - p. 104217 , 2022

Link: https://doi.org/10.1016/..

8

Clinico-epidemiological and genomic profile of first Zika V..:

Malhotra, Bharti ; Gupta, Veenu ; Sharma, Pratibha...
Journal of Infection and Public Health. 13 (2020) 12 - p. 1920-1926 , 2020

Link: https://doi.org/10.1016/..

9

Immunogenicity and safety of Biological E's CORBEVAX™ vacci..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, SubbaReddy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294721/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Pre-existing antibody levels negatively correlate with anti..:

Das, Suman ; Singh, Janmejay ; Shaman, Heena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199457/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Sub-optimal neutralisation of omicron (B.1.1.529) variant b..:

Medigeshi, Guruprasad R ; Batra, Gaurav ; Murugesan, Deepika Rathna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923830/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Immunogenicity and safety of Biological E's CORBEVAX™ vacci..:

Subhash Thuluva ; Vikram Paradkar ; SubbaReddy Gunneri...
http://dx.doi.org/10.1080/21645515.2023.2203632. , 2023

Link: https://doi.org/10.1080/..

13

Evaluation of safety and immunogenicity of receptor-binding..:

Subhash Thuluva ; Vikram Paradkar ; Subba Reddy Gunneri...
http://www.sciencedirect.com/science/article/pii/S2352396422003991. , 2022

Link: https://doi.org/10.1016/..

14

Humoral cross-reactivity towards SARS-CoV-2 in young childr..:

Nitin Dhochak ; Tanvi Agrawal ; Heena Shaman...
http://www.sciencedirect.com/science/article/pii/S2667038022000011. , 2022

Link: https://doi.org/10.1016/..

15

Sub-optimal neutralisation of omicron (B.1.1.529) variant b..:

Guruprasad R Medigeshi ; Gaurav Batra ; Deepika Rathna Murugesan...
http://www.sciencedirect.com/science/article/pii/S2352396422001220. , 2022

Link: https://doi.org/10.1016/..